These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 9209586
1. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle. Martinez ZA, Colgan M, Baxter LR, Quintana J, Siegel S, Chatziioannou A, Cherry SR, Mazziotta JC, Phelps ME. Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586 [Abstract] [Full Text] [Related]
2. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study. Kinnala A, Suhonen-Polvi H, Aärimaa T, Kero P, Korvenranta H, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Nuutila P, Wegelius U. Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676 [Abstract] [Full Text] [Related]
11. A kinetic comparison of [18F]2-fluoro-2-deoxyglucose and [18F]2-fluoro-2-deoxymannose using positron emission tomography. Braun AR, Carson RE, Adams HR, Finn RD, Francis BE, Herscovitch P. Nucl Med Biol; 1994 Aug; 21(6):857-63. PubMed ID: 9234335 [Abstract] [Full Text] [Related]
12. Noninvasive determination of local cerebral metabolic rate of glucose in man. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Am J Physiol; 1980 Jan; 238(1):E69-82. PubMed ID: 6965568 [Abstract] [Full Text] [Related]
14. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. Oku N, Tokudome Y, Namba Y, Saito N, Endo M, Hasegawa Y, Kawai M, Tsukada H, Okada S. Biochim Biophys Acta; 1996 Apr 03; 1280(1):149-54. PubMed ID: 8634309 [Abstract] [Full Text] [Related]
19. FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy. Reinhardt MJ, Müller-Mattheis VG, Gerharz CD, Vosberg HR, Ackermann R, Müller-Gärtner HW. J Nucl Med; 1997 Jan 03; 38(1):99-101. PubMed ID: 8998160 [Abstract] [Full Text] [Related]
20. Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism. Szymanski S, Gur RC, Gallacher F, Mozley LH, Gur RE. Neuropsychopharmacology; 1996 Dec 03; 15(6):567-75. PubMed ID: 8946431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]